Eli Lilly holds the lead position in the weight management market right now. But Viking Therapeutics is working on a ...
Strong demand for Mounjaro and Zepbound is expected to power LLY's Q3 growth, as both drugs deepen U.S. and global market ...
Zacks Investment Research on MSN
NVO, OMER Ink $2.1B Zaltenibart Deal to Bolster Rare Disease Portfolio
Novo Nordisk NVO and Omeros Corporation OMER have announced the signing of a definitive asset purchase and license agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback